The Christie NHS FT Annual Report & Accounts 2019-20

Directors’ Report

UK, winning the Nye Bevan award in 1992 and more than 60 support and information units have been established based on this model. She has published widely and is a UK representative for cancer survivorship in Europe and advises on cancer survivorship programmes in Denmark and Canada.

rating in the regulation of healthcare organisations and services; organisational capabilities and processes for improvement; and health and social care devolution.

Professor Jane Maher Non-executive director

Jane was appointed from September 2015. She is the non-executive director safeguarding lead and is a member of the Quality Assurance Committee. Jane was Chief Medical Officer of Macmillan Cancer Support from 1999-2018 and remains a clinical advisor to the charity. She has worked as a consultant clinical oncologist at Mount Vernon Cancer Centre for nearly 30 years and over this period focussed on a range of different cancers, including lymphoma, head and neck cancer and lung cancer, most recently with a particular interest in breast and advanced prostate cancer, with a research interest in understanding what happens to patients after their initial cancer treatment, as well as the influence of cultural differences on cancer management. She has also advised national NHS and international bodies on aftercare and survivorship. Jane chaired the Maher Committee for the Department of Health in 1995, led the UK National Audit of Late Effects Pelvic Radiotherapy for the Royal College of Radiologists in 2000 and chaired the National Cancer Survivorship Initiative Consequences of Treatment workstream. She co-founded one of the first cancer support and Information services in the

Robert Ainsworth Non-executive director

Robert was appointed in March 2016 . He is a member of the Audit Committee and is the independent Chairman of The Christie Pharmacy Limited. Robert was previously a non-executive director of Pennine Care NHS Foundation Trust having been appointed in 2008, and served as deputy chairman and senior independent director from 2011 until 2016 . Prior to taking up the role of non-executive director, Robert held several senior management and director positions in the private sector, most recently in Premier Farnell plc, where he was Finance Director of the Europe & Asia Pacific division. This consisted of over twenty businesses across Europe and Asia with a turnover in excess of £400 million. He was previously Finance Director and Company Secretary of National Tyres and Autocare Ltd and was Executive Director of Finance of GUS Catalogue Order Ltd. He has also been employed by The Co-operative Bank plc, and Price Waterhouse & Co. He has wide experience of general and financial management and much of

103